|
No. | Age | Gender | Primary tumor | Antineoplastic agents | Analgesic drugs | Painful bone metastasis | Radiotherapy protocol |
|
1 | 67 | Female | Lung cancer | Icotinib | Tramadol, gabapentin, zoledronate | L3/4 | 10 MV-X line 3D-CRT DT 30 Gy/10 F |
2 | 54 | Male | Lung cancer | Osimertinib | Tramadol | C3/4 | MLC 3DCR-T-SAD DT 30 Gy/10 F |
3 | 68 | Female | Lung cancer | Icotinib | Tramadol | Left ilium, left lip | 10 MV-X line 3D-CRT DT 30 Gy/10 F |
4 | 65 | Male | renal cancer | Sorafenib | Tramadol | Left ilium | 10 MV-X line 3D-CRT DT 30 Gy/10 F |
5 | 69 | Female | Lung cancer | Osimertinib | Tramadol | Right whirlbone | MLC 3DCR-T-SAD DT 30 Gy/10 F |
6 | 66 | Male | Lung cancer | Bicalutamide | Tramadol, zoledronate | Right lip | MLC 3DCR-T-SAD DT 30 Gy/10 F |
7 | 70 | Male | Lung cancer | Icotinib | Zoledronate | Right ilium | 10 MV-X line 3D-CRT DT 45 Gy/15 F |
8 | 62 | Female | Lung cancer | — | Oxycodone | C4 | 10 MV-X line 3D-CRT DT 30 Gy/10 F |
9 | 66 | Female | Colorectal cancer | Bevacizumab | Tramadol, zoledronate | Left lip | 10 MV-X line 3D-CRT DT 30 Gy/10 F |
10 | 65 | Female | Gallbladder carcinoma | — | Oxycodone | L3-5 | MLC 3DCR-T-SAD DT 30 Gy/10 F |
11 | 56 | Female | Liver cancer | Regorafenib | Tramadol, gabapentin, zoledronate | Right ilium | 10 MV-X line 3D-CRT DT 30 Gy/10 F |
12 | 67 | Male | Renal cancer | — | Tramadol | Right ilium | 10 MV-X line 3D-CRT DT 30 Gy/10 F |
13 | 64 | Male | Colorectal cancer | — | Tramadol, gabapentin | Right ilium | 10 MV-X line 3D-CRT DT 30 Gy/10 F |
14 | 67 | Male | Liver cancer | Gefitinib | Tramadol, gabapentin | T11 | 10 MV-X line 3D-CRT DT 30 Gy/10 F |
15 | 46 | Female | Liver cancer | Lenvatinib | Tramadol | S1, left ilium, left whirlbone | 10 MV-X line IMRT PTV DT 50 Gy/20 F |
16 | 74 | Female | Lung cancer | Gefitinib | Tramadol, zoledronate | L5-S1 | 10 MV-X line IMRT GTV DT 30 Gy/10 F |
17 | 53 | Female | Lung cancer | Icotinib | Tramadol, zoledronate | Right arm | 10 MV-X line 3D-CRT DT 30 Gy/10 F |
18 | 38 | Female | Ovarian cancer | Bevacizumab | Tramadol | L3 | 10 MV-X line 3D-CRT DT 30 Gy/10 F |
19 | 57 | Male | Lung cancer | Bevacizumab | Tramadol | T12, L1-4 | 10 MV-X line 3D-CRT DT 30 Gy/10 F |
20 | 74 | Female | Lung cancer | Teriprizumab | Oxycodone | L5 | 10 MV-X line IMRT PTV DT 30 Gy/10 F |
21 | 86 | Male | Lung cancer | — | Tramadol | T8/9 | 10 MV-X line IMRT PTV DT 45 Gy/15 F |
22 | 55 | Male | Liver cancer | Sorafenib | Oxycodone, gabapentin | Right clavicle, scapula, humerus | 10 MV-X line 3D-CRT DT 30 Gy/10 F |
23 | 61 | Male | Prostate cancer | Bicalutamide | Tramadol | T10-L1 | 10 MV-X line 3D-CRT DT 30 Gy/10 F |
24 | 59 | Female | Lung cancer | Osimertinib | Tramadol | Left ilium | 10 MV-X line IMRT PTV DT 33 Gy/11 F |
25 | 55 | Female | Breast cancer | Anastrozole | Tramadol, zoledronate | T11-L2 | 10 MV-X line IMRT PTV DT 30 Gy/10 F |
26 | 72 | Male | Lung cancer | — | Tramadol | Left femur | 10 MV-X line IMRT PTV DT 45 Gy/15 F |
27 | 61 | Female | Colorectal cancer | — | Gabapentin | T12, L1-5 | 10 MV-X line 3D-CRT DT 30 Gy/10 F |
28 | 69 | Male | Lung cancer | Bevacizumab | Tramadol | T11/12 | MLC 3DCR-T-SAD DT 30 Gy/10 F |
29 | 60 | Female | Lung cancer | Gefitinib | Tramadol, zoledronate | C5/6 | 10 MV-X line IMRT PTV DT 45 Gy/15 F |
30 | 63 | Male | Lung cancer | Cindillizumab | Tramadol | S1 | 10 MV-X line IMRT PTV DT 30 Gy/10 F |
|